A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug. The University of Manchester and Salford ...

Nov. 12, 2024 — Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other ...

we still don’t have a cure for psoriasis. But more is now known about how the condition works. It is caused by a fault in the immune system which triggers the over-production of new skin cells.

Innovative research has provided compelling evidence that perceived stress can directly trigger the relapse of psoriatic skin ...

"Psoriasis is a chronic skin condition affecting approximately 60 million people worldwide, significantly impacting their lives. Its origins are complex, involving genetic and environmental factors, ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

Around 1.7% of the UK population are affected by the chronic skin condition psoriasis, according to researchers at The University of Manchester and the University Medical Center Hamburg-Eppendorf. The ...

The abstracts for the CRP and supporting cores are summarized below. The overall goal of the CWRU Psoriasis Center of Research Translation (CORT) is to combine new bioinformatic methodologies with ...

It comes from vitamin A. Patients with severe psoriasis who test positive for HIV (human immunodeficiency virus) Unlike other medicine for severe psoriasis, oral retinoids do NOT suppress the immune ...

Psoriasis medicine: Psoriasis is often a lifelong condition that requires a long-term treatment strategy. Psoriasis tends to come and go unexpectedly. People often have periods when psoriasis calms ...

Objective We aimed to investigate the relationship between tumour necrosis factor inhibitors (TNFi) therapy and the onset of new psoriasis in children with juvenile idiopathic arthritis (JIA) using ...